
Sign up to save your podcasts
Or
We love to hear from our listeners. Send us a message.
Tessera Therapeutics' CEO, Dr. Michael Severino, joins Host Erin Harris to discuss Gene Writing, the biotech's genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Severino discusses why delivery has always been a challenge for gene editing technologies and why Gene Writing is different when it comes to efficient delivery.
Subscribe to the podcast!
Apple | Spotify | YouTube
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Tessera Therapeutics' CEO, Dr. Michael Severino, joins Host Erin Harris to discuss Gene Writing, the biotech's genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Severino discusses why delivery has always been a challenge for gene editing technologies and why Gene Writing is different when it comes to efficient delivery.
Subscribe to the podcast!
Apple | Spotify | YouTube
764 Listeners
32,056 Listeners
1,004 Listeners
523 Listeners
3,548 Listeners
8,326 Listeners
116 Listeners
314 Listeners
59 Listeners
8,214 Listeners
82 Listeners
27 Listeners
143 Listeners
14 Listeners
44 Listeners